振东制药
(300158)
| 流通市值：46.72亿 | | | 总市值：46.85亿 |
| 流通股本：10.03亿 | | | 总股本：10.05亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 466,171,059.82 | 584,592,028.36 | 371,437,996.8 | 484,678,625.09 |
| 应收票据及应收账款 | 713,549,392.45 | 575,403,850.66 | 756,861,748.07 | 693,100,102.92 |
| 其中：应收票据 | 46,641,522.45 | 55,854,094.12 | 76,430,239.7 | 80,164,192.22 |
| 应收账款 | 666,907,870 | 519,549,756.54 | 680,431,508.37 | 612,935,910.7 |
| 应收款项融资 | 169,722,945.62 | 142,664,197.5 | 95,114,192.62 | 60,364,756.17 |
| 预付款项 | 65,149,815.34 | 66,181,019.8 | 127,241,463.08 | 129,248,555.32 |
| 其他应收款合计 | 73,522,297 | 57,745,074.09 | 87,035,237.01 | 77,467,156.75 |
| 存货 | 643,059,761.36 | 775,978,314.86 | 1,088,764,079.93 | 1,135,581,472.43 |
| 其他流动资产 | 18,756,297.84 | 23,427,523.51 | 17,529,595.38 | 15,114,150.24 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,858,122,396.26 | 3,215,616,760 | 3,952,475,367.21 | 4,060,367,253.17 |
| 非流动资产: | | | | |
| 长期股权投资 | 28,631,287.85 | 28,742,700.59 | - | - |
| 其他权益工具投资 | 14,909,606.16 | 9,909,606.16 | 87,323,136.76 | 87,323,136.76 |
| 投资性房地产 | 14,060,837.5 | 14,844,321.37 | 14,463,850.75 | 15,247,334.62 |
| 固定资产 | 909,805,743 | 924,468,422.55 | 906,021,262.57 | 920,604,228.06 |
| 在建工程 | 123,021,350.11 | 119,395,906.33 | 100,525,119.99 | 71,464,688.08 |
| 生产性生物资产 | - | - | 904,962.99 | 904,962.99 |
| 使用权资产 | 2,304,607.65 | 2,624,915.68 | 2,013,441.04 | 2,263,257.44 |
| 无形资产 | 283,658,190.63 | 288,845,891.24 | 248,861,831.39 | 252,031,213.17 |
| 开发支出 | 84,816,513.42 | 83,057,493.92 | 207,921,080.07 | 194,592,640 |
| 商誉 | 15,499,814.18 | 15,499,814.18 | 40,239,614.18 | 40,239,614.18 |
| 长期待摊费用 | 16,659,493.09 | 18,307,511.85 | 8,922,334.65 | 7,231,616.93 |
| 递延所得税资产 | 25,403,002.07 | 24,966,358.08 | 21,305,348.61 | 20,680,349.08 |
| 其他非流动资产 | 257,685,970.86 | 236,444,843.78 | 290,647,838.45 | 251,974,466.85 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,776,456,416.52 | 1,767,107,785.73 | 1,929,149,821.45 | 1,864,557,508.16 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,634,578,812.78 | 4,982,724,545.73 | 5,881,625,188.66 | 5,924,924,761.33 |
| 流动负债: | | | | |
| 短期借款 | 15,252,477.64 | 38,109,647.77 | - | - |
| 应付票据及应付账款 | 280,322,055.43 | 328,010,227.32 | 326,030,729.45 | 382,018,290.13 |
| 其中：应付票据 | 19,195,008.23 | 26,254,686.7 | 28,866,631.61 | 43,588,503.01 |
| 应付账款 | 261,127,047.2 | 301,755,540.62 | 297,164,097.84 | 338,429,787.12 |
| 合同负债 | 49,966,144.87 | 51,415,048.96 | 61,271,106.67 | 62,748,714.62 |
| 应付职工薪酬 | 22,327,674.67 | 37,411,874.39 | 27,020,811.55 | 26,160,549.67 |
| 应交税费 | 34,692,008.11 | 14,490,826.56 | 41,881,134.47 | 26,085,144.83 |
| 其他应付款合计 | 529,885,166.4 | 772,222,655.5 | 254,136,112.48 | 247,227,857.64 |
| 一年内到期的非流动负债 | 569,137.95 | 2,012,943.15 | 1,296,190.8 | 1,257,564.67 |
| 其他流动负债 | 11,568,131.51 | 11,362,044.59 | 20,218,896.41 | 35,662,826.49 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 944,582,796.58 | 1,255,035,268.24 | 731,854,981.83 | 781,160,948.05 |
| 非流动负债: | | | | |
| 租赁负债 | 948,216.27 | 1,088,628.95 | 969,791.88 | 969,791.88 |
| 长期应付款 | 27,715,173.03 | 27,715,173.03 | 27,715,173.03 | 27,715,173.03 |
| 递延收益 | 36,655,136.5 | 37,650,654.97 | 39,785,967.42 | 41,235,793.14 |
| 递延所得税负债 | 957,599.45 | 978,553.95 | 1,326,106.67 | 2,307,300.23 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 66,276,125.25 | 67,433,010.9 | 69,797,039 | 72,228,058.28 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,010,858,921.83 | 1,322,468,279.14 | 801,652,020.83 | 853,389,006.33 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,005,319,756 | 1,005,319,756 | 1,005,319,756 | 1,027,494,660 |
| 资本公积 | 3,681,733,558.19 | 3,681,733,558.19 | 3,681,733,558.19 | 3,762,314,237.72 |
| 减:库存股 | 40,381,108.51 | 2,838,312.11 | - | 102,755,583.53 |
| 其他综合收益 | -79,777,530.24 | -79,778,182.56 | -32,403,703.53 | -32,377,816.06 |
| 盈余公积 | 481,346,118.6 | 481,346,118.6 | 481,346,118.6 | 481,346,118.6 |
| 未分配利润 | -1,386,996,474.81 | -1,388,153,651.67 | -19,466,420.29 | -28,932,272.59 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,661,244,319.23 | 3,697,629,286.45 | 5,116,529,308.97 | 5,107,089,344.14 |
| 少数股东权益 | -37,524,428.28 | -37,373,019.86 | -36,556,141.14 | -35,553,589.14 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,623,719,890.95 | 3,660,256,266.59 | 5,079,973,167.83 | 5,071,535,755 |
| 负债和股东权益合计 | 4,634,578,812.78 | 4,982,724,545.73 | 5,881,625,188.66 | 5,924,924,761.33 |
| 公告日期 | 2025-04-21 | 2025-04-21 | 2024-10-24 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |